TSE Explores Drug Discovery – Identifying and Optimizing a Promising Drug
Video
Last Updated: July 9, 2020
(+ more)
Published: May 28, 2020
|
Laura Elizabeth Lansdowne
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
Learn about our editorial policies
&
Tiffany Quinn
After obtaining a bachelor in neuroscience from the University of Leeds, Tiffany joined Technology Networks to pursue a career in science communication as a custom content producer and manager. She has helped grow the company’s custom content services through creating high-quality and engaging content for client’s target audiences. Tiffany left TN in 2023 to pursue other career goals.
Learn about our editorial policies
In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.
Meet the Authors
Managing Editor
Laura Lansdowne is the managing editor at Technology Networks, she holds a first-class honors degree in biology. Before her move into scientific publishing, Laura worked at the Wellcome Sanger Institute and GW Pharma.
After obtaining a bachelor in neuroscience from the University of Leeds, Tiffany joined Technology Networks to pursue a career in science communication as a custom content producer and manager. She has helped grow the company’s custom content services through creating high-quality and engaging content for client’s target audiences. Tiffany left TN in 2023 to pursue other career goals.
Advertisement